Treatment as prevention
Michael Horberg, MD, devotes his career to transforming how HIV/AIDS patients are treated at Kaiser Permanente and throughout the United States.
Michael Horberg, MD, highlights Hepatitis C screening program
Michael Horberg, MD, executive director of the Mid-Atlantic Permanente Research Institute, represented Kaiser Permanente at an invitation-only meeting to discuss the evidence for early hepatitis C treatment in the United States.